News

Drug Development Is Slowing Down After Cuts at the FDA
The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.
Prostate cancer drug now available to more patients with aggressive form of disease
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...
Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Experimental GLP-1 pill helped people with diabetes lose weight and lower blood sugar, Eli Lilly says
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...
GLP-1 pill from Eli Lilly leads to weight loss, lowers blood sugar without injections
In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.
The Hill8d
FDA to phase out some animal testing requirements, possibly replace them with AI models
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological products and drugs, instead moving toward alternative testing models ...
Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...